3. Glasgow Declaration
AE and members adopt Glasgow Declaration calling for:
• a rights based approach to dementia,
• development of national dementia strategies in all European
countries,
• development of a European dementia strategy with increased
funding for dementia research and improved exchange of
good practices,
• greater global collaboration on dementia.
3
4. Our campaign was supported by
• 195 organisations from
32 countries
• 150 policy makers
from 25 European
countries
AND
• Over 11’600 European
citizens
4
6. EU achievements - Research
• EUR 555 million funding on dementia under FP7
• EUR 170 million by Innovative Medicines Initiative
– (PharmaCog, EMIF, AETIONOMY & EPAD)
• JPND – Joint Programme Neurodegenerative Disease
Research
– 28 participating countries including Canada, Albania, Canada, Israel,
Norway, Switzerland, Turkey)
– 15 ongoing projects (2011-2014) for EUR 68.5 million
6
7. Luxembourg Presidency Conclusions 12/2015
• Call on European Commission and Member States
– Recognise Governmental expert group on dementia
– Intensify research on dementia
– Identify and exchange good practices on prevention, timely diagnosis,
post-diagnostic support, treatment and care, training of health
professionals
– Improve epidemiological information on dementia
– Support non-governmental organisations in the field of dementia
7
8. Dutch EU Presidency
• Presidency Conference (9-10
May 2016)
• Living well with(out) dementia
– Living well without dementia –
Prevention
– Living well with dementia at home
– Living well with dementia in care
homes
8
9. 2nd Joint Action on Dementia
• Duration:
– 2016-2018
• Priority actions:
– Diagnosis and post-diagnostic support, crisis and care coordination,
residential care, dementia-friendly communities
• Countries involved:
– Lead: United Kingdom (Scottish Government)
– Partners: Bulgaria, France, Greece, Italy, Netherlands, Norway,
Portugal, Romania, Spain, United Kingdom (Department of Health) 9